Clinical Trial Update: A Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Participants With Pulmonary Arterial Hypertension [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating a mean pulmonary artery pressure-targeted approach with early Treprostinil therapy to reverse right ventricular remodeling …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Treprostinil (treprostinil)

Snippet

Sponsor: United Therapeutics | Conditions: Pulmonary Arterial Hypertension | Phase 4 | Status: ACTIVE_NOT_RECRUITING